Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Dapagliflozin in Mangement of Pulmonary Hypertension Patients

NCT06612086 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06612086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06612086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Dapagliflozin in Mangement of Pulmonary Hypertension Patients
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 25, 2024
Completion date
October 10, 2026
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension